共 50 条
High Affinity Fluorescent Probe for Proteinase-Activated Receptor 2 (PAR2)
被引:6
|作者:
LeSarge, Jordan C.
[1
]
Thibeault, Pierre
[2
]
Milne, Mark
[5
]
Ramachandran, Rithwik
[2
]
Luyt, Leonard G.
[1
,3
,4
,5
]
机构:
[1] Univ Western Ontario, Dept Chem, 1151 Richmond St, London, ON N6A 3K7, Canada
[2] Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St, London, ON N6A 3K7, Canada
[3] Univ Western Ontario, Dept Oncol, 1151 Richmond St, London, ON N6A 3K7, Canada
[4] Univ Western Ontario, Dept Med Imaging, 1151 Richmond St, London, ON N6A 3K7, Canada
[5] Lawson Hlth Res Inst, London Reg Canc Program, 800 Commissioners Rd East, London, ON N6A 5W9, Canada
来源:
ACS MEDICINAL CHEMISTRY LETTERS
|
2019年
/
10卷
/
07期
基金:
加拿大自然科学与工程研究理事会;
加拿大健康研究院;
关键词:
Proteinase-activated receptor 2 (PAR2);
peptide;
targeted fluorescent probes;
fluorescence imaging;
structure-activity relationship;
MOLECULAR-CLONING;
EXPRESSION;
POTENT;
BINDING;
PROTEASE-ACTIVATED-RECEPTOR-1;
2-FUROYL-LIGRLO-AMIDE;
AGONISTS;
PEPTIDE;
GROWTH;
CANCER;
D O I:
10.1021/acsmedchemlett.9b00094
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
PAR2 is a proteolytically activated G protein coupled receptor (GPCR) that is implicated in various cancers and inflammatory diseases. Ligands with low nano molar affinity for PAR2 have been developed, but there is a paucity of research on the development of PAR2-targeting imaging probes. Here, we report the development of seven novel PAR2-targeting compounds. Four of these compounds are highly potent and selective PAR2-targeting peptides (EC50 = 10 to 23 nM) that have a primary amine handle available for facile conjugation to various imaging components. We describe a peptide of the sequence Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2 as the most potent and highest affinity PAR2-selective fluorescent probe reported to date (EC50 = 16 nM, K-D = 38 nM). This compound has a greater than 10-fold increase in potency and binding affinity for PAR2 compared to the leading previously reported probe and is conjugated to a red-shifted fluorophore, enabling in vitro and in vivo studies.
引用
收藏
页码:1045 / 1050
页数:11
相关论文